Glycol nucleic acid
Glycol nucleic acid (GNA), sometimes also referred to as glycerol nucleic acid, is a nucleic acid similar to DNA or RNA but differing in the composition of its sugar-phosphodiester backbone, using propylene glycol in place of ribose or deoxyribose.[1] GNA is chemically stable but not known to occur naturally. However, due to its simplicity, it might have played a role in the evolution of life.
The 2,3-dihydroxypropyl nucleoside analogues were first prepared by Ueda et al. (1971). Soon thereafter it was shown that phosphate-linked oligomers of the analogues do in fact exhibit hypochromicity in the presence of RNA and DNA in solution (Seita et al. 1972). The preparation of the polymers was later described by Cook et al. (1995, 1999) and Acevedo and Andrews (1996). However the ability of GNA-GNA self-pairing was first reported by Zhang and Meggers in 2005.[1] Crystal structures of a GNA duplexes were subsequently reported by Essen and Meggers.[2][3]
DNA and RNA have a
See also
References
Further reading
- Zhang L, Peritz A, Meggers E (March 2005). "A simple glycol nucleic acid". Journal of the American Chemical Society. 127 (12): 4174–5. PMID 15783191.
- Seita T, Yamauchi K, Kinoshita M, Imoto M (April 1972). "Condensation polymerization of nucleotide analogues". Die Makromolekulare Chemie: Macromolecular Chemistry and Physics. 154 (1): 255–61. .
- Ueda N, Kawabata T, Takemoto K (October 1971). "Synthesis of N‐(2, 3‐dihydroxypropyl) derivatives of nucleic bases". Journal of Heterocyclic Chemistry. 8 (5): 827–9. .
- Acevedo OL, Andrews RS (June 1996). "Synthesis of propane-2, 3-diol combinatorial monomers". Tetrahedron Letters. 37 (23): 3931–4. .
- WO 9518820, Cook PD, Acevedo OL, Davis PW, Ecker DJ, Hebert N, "Synthesis of acyclic oligonucleotides as antiviral and antiinflammatory agents and inhibitors of phospholipase A2.", published 13 July 1995
- US 5886177, Cook PD, Acevedo OL, Davis PW, Ecker DJ, Hebert N, "Preparation of ethylene glycol phosphate linked oligodeoxyribonucleotides as phospholipase A2 inhibitors.", issued 23 March 1999, assigned to ISIS Pharmaceuticals Inc.
External links
- Simpler than DNA - Chemical & Engineering News